Translational Oncology, 1936-5233

Tidskrift

Fler filtreringsmöjligheter
  1. 2021
  2. Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine

    Ildikó Fritz, Philippe Wagner & Håkan Olsson, 2021, I: Translational Oncology. 14, 4, 101029.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2015
  4. Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival.

    Jenny-Maria Jönsson, Nicolai Arildsen, Susanne Malander, Anna Måsbäck, Linda Werner Hartman, Mef Nilbert & Ingrid Hedenfalk, 2015, I: Translational Oncology. 8, 5, s. 424-433 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2013
  6. Impact of perfusion map analysis on early survival prediction accuracy in glioma patients.

    Benjamin Lemasson, Thomas L Chenevert, Theodore S Lawrence, Christina Tsien, Pia Sundgren, Charles R Meyer, Larry Junck, Jennifer Boes, Stefanie Galbán, Timothy D Johnson, Alnawaz Rehemtulla, Brian D Ross & Craig J Galbán, 2013, I: Translational Oncology. 6, 6, s. 766-774

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.

    Kristoffer von Stedingk, Jan Koster, Marta Piqueras, Rosa Noguera, Samuel Navarro, Sven Påhlman, Rogier Versteeg, Ingrid Øra, David Gisselsson Nord, David Lindgren & Håkan Axelson, 2013, I: Translational Oncology. 6, 4, s. 447-457 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2011
  9. RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer.

    Osa Ehlen, Björn Nodin, Elton Rexhepaj, Jenny Brändstedt, Mathias Uhlen, Maria Alvarado-Kristensson, Fredrik Pontén, Donal J Brennan & Karin Jirström, 2011, I: Translational Oncology. 4, 4, s. 212-221

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift